Pharmaceuticals New Zealand

New Zealand Testosterone Replacement Therapy Market Analysis, 2024–2034

Updated Reviewed by Chandani Patel

New Zealand Testosterone Replacement Therapy Market Industry Trends and Forecast to 2034: Segmented by (Form, Channel, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

New Zealand · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $18.9 Mn Placeholder estimate
Estimate 2025 $19.6 Mn 0.9% of the global market
Projected 2034 $27.7 Mn 41.1% Adds $8.1 Mn over 9 forecast years
CAGR 2025–2034 3.9% Faster than 5% of 160 Pharmaceuticals markets here
Key players 5
  • New Zealand is 0.91% of the global market.
  • In APAC, the largest is China at $169.1 Mn.
  • Fastest growing: India at 7.1% a year.
  • New Zealand ranks 5th of 10 by size in APAC.

Market size projection

New Zealand

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$8.1 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Testosterone Replacement Therapy Market market size by year, New Zealand
YearMarket sizeChange that yearSince 2025
2024 (estimate) $18.9 Mn — —
2025 (base) $19.6 Mn +$0.7 Mn —
2026 (forecast) $20.4 Mn +$0.8 Mn +3.9%
2027 (forecast) $21.2 Mn +$0.8 Mn +8%
2028 (forecast) $22.0 Mn +$0.8 Mn +12.2%
2029 (forecast) $22.9 Mn +$0.9 Mn +16.5%
2030 (forecast) $23.8 Mn +$0.9 Mn +21.1%
2031 (forecast) $24.7 Mn +$0.9 Mn +25.8%
2032 (forecast) $25.7 Mn +$1.0 Mn +30.7%
2033 (forecast) $26.7 Mn +$1.0 Mn +35.8%
2034 (forecast) $27.7 Mn +$1.0 Mn +41.1%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Same market worldwide

By geography

  1. Global $2.16 Bn
  2. North America $973.9 Mn
  3. US $749.7 Mn
  4. Europe $414.0 Mn
  5. APAC $408.0 Mn
  6. Canada $186.1 Mn
  7. China $169.1 Mn
  8. Japan $153.4 Mn
  9. Latin America $96.7 Mn
  10. Middle East $92.6 Mn
  11. Germany $85.0 Mn
  12. France $66.7 Mn
  13. UK $61.2 Mn
  14. Brazil $53.3 Mn
  15. Italy $49.5 Mn
  16. India $43.8 Mn
  17. Ecuador $38.8 Mn
  18. Spain $36.1 Mn
  19. Saudi Arabia $36.8 Mn
  20. Mexico $35.5 Mn
  21. Africa $33.5 Mn
  22. Australia $29.4 Mn
  23. Russia $20.3 Mn
  24. New Zealand (this report) $19.6 Mn
  25. South Africa $16.3 Mn
  26. UAE $11.2 Mn
  27. Egypt $6.3 Mn
  28. Philippines $5.4 Mn
  29. Hong Kong $3.7 Mn
  30. Malaysia $3.3 Mn
  31. Singapore $2.6 Mn
  32. Thailand $2.4 Mn
  33. Kenya $1.6 Mn

Report snapshot

New Zealand Testosterone Replacement Therapy Market Analysis at a glance
Market size, 2025$19.6 Mn placeholder estimate
Forecast, 2034$27.7 Mn placeholder estimate
Growth (CAGR), 2025–20343.9% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsForm, channel and end user (see all)
Key playersAbbVie Inc., Endo Pharmaceuticals, Pfizer Inc., Clarus Therapeutics, Marius Pharmaceuticals (see all)
Regulator in New ZealandMedsafeSource: Medsafe. Checked 14 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The New Zealand Testosterone Replacement Therapy Market Analysis Executive Summary

Testosterone replacement therapy treats low testosterone in men with gels, injections, patches and pellets.

Key segments of the testosterone Replacement Therapy market include form (Injections, Gels and Patches) and channel (Clinics, Telehealth and Pharmacies).

Bar chart: New Zealand Testosterone Replacement Therapy market size, 2024–2034, placeholder estimates. $18.9 Mn in 2024, $19.6 Mn in 2025 and $27.7 Mn in 2034, 3.9% CAGR.
New Zealand Testosterone Replacement Therapy market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

New Zealand Testosterone Replacement Therapy Market Dynamics

Market Growth Drivers

An ageing male population, more men seeking care, less invasive procedures and telehealth for sensitive conditions are driving the testosterone Replacement Therapy market.

Opportunity

Office-based procedures, direct-to-consumer telehealth and wider insurance coverage give the testosterone Replacement Therapy market room to grow.

Market Restraints

Stigma, out-of-pocket costs and limited reimbursement for some procedures hold back the testosterone Replacement Therapy market.

Competitive Landscape for Testosterone Replacement Therapy Market in New Zealand

The testosterone Replacement Therapy market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Testosterone Replacement Therapy Market in New Zealand

Testosterone Replacement Therapy in New Zealand: rules and payment

Medsafe, part of the Ministry of Health, approves medicines before they can be sold.⁠[1] Pharmac decides which medicines and medical devices the public health system pays for.⁠[2]

[1] Medsafe. Checked 14 Nov 2026.

[2] Pharmac. Checked 14 Nov 2026.

Policy changes and Reimbursement scenario

Regulators such as the US FDA, the European Medicines Agency and national drug authorities set approval, pricing and safety rules for testosterone Replacement Therapy. Reimbursement decisions by public payers and insurers shape how fast new therapies reach patients in New Zealand.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Testosterone Replacement Therapy right now, from free public sources.

Latest research 648 papers since 2021 (worldwide)

  1. [Changes of age-related androgen and their significance in males]. Zhonghua nan ke xue = National journal of andrology, 2026
  2. A novel in-vitro skin model to assess secondary transfer of applied testosterone following skin to skin contact. European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 2026
  3. Ocular Considerations for the Department of War's New Testosterone Initiative. Military medicine, 2026
  4. Testosterone replacement therapy and aneurysm biology: current evidence and clinical implications. Indian journal of thoracic and cardiovascular surgery, 2026
  5. The Impact of Vitamin E Intake on Cardiometabolic Outcomes of Testosterone Replacement Therapy in Men with Late-Onset Hypogonadism. International journal of molecular sciences, 2026
Search all of them on PubMed (opens in a new tab)

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Testosterone Replacement Therapy in context

New Zealand compared

  • Health spending per person: 5,022 US$ per person (2024). World: 1,317 US$ per person (2023). 2nd highest of the 15 countries we cover in APAC.[1]
  • Doctors: 3.61 per 1,000 people (2022). World: 1.86 per 1,000 people (2022). 2nd highest of the 15 countries we cover in APAC.[2]
  • People aged 65 and over: 17.6% of people (2025). World: 10.4% of people (2025). 4th highest of the 16 countries we cover in APAC.[3]

[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 14 Nov 2026.

[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 14 Nov 2026.

[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 15 Nov 2026.

Free data on this topic

Quick answers

Frequently asked questions

How big is the Testosterone Replacement Therapy market in New Zealand?
Placeholder estimate: about $19.6 Mn in 2025, rising to about $27.7 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Testosterone Replacement Therapy market in New Zealand growing?
Placeholder estimate: about 3.9% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Testosterone Replacement Therapy market report cover?
The report splits the market by form (Injections, Gels, Patches, Oral and more), channel (Clinics, Telehealth, Pharmacies) and end user (Hospitals, Specialty Clinics, Retail Pharmacies, Online Pharmacies).
Who are the key players in the Testosterone Replacement Therapy market?
Key players include AbbVie Inc., Endo Pharmaceuticals, Pfizer Inc., Clarus Therapeutics and Marius Pharmaceuticals.
What is driving the Testosterone Replacement Therapy market?
An ageing male population, more men seeking care, less invasive procedures and telehealth for sensitive conditions are driving the testosterone Replacement Therapy market.
Who regulates Testosterone Replacement Therapy in New Zealand?
Medsafe, part of the Ministry of Health, approves medicines before they can be sold. Source: Medsafe. Checked 14 Nov 2026.
How is healthcare paid for in New Zealand?
Pharmac decides which medicines and medical devices the public health system pays for. Source: Pharmac. Checked 14 Nov 2026.
How much research is published on Testosterone Replacement Therapy?
PubMed lists 648 papers on Testosterone Replacement Therapy added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Get a free sample The table of contents and sample pages. No payment needed. Request sample Consult Us Questions about Testosterone Replacement Therapy in New Zealand? Our analysts can size it for your plan. Talk to us See the public data Health figures for every country, free. Open the Public Health Dashboard

From our blog

Men's Health Supplements: Beyond the MarketingOnly about a quarter of testosterone booster products had study data showing they raise testosterone. Sexual… Fertility Services: Rising Demand and Access GapsAbout 1 in 6 adults experience infertility. In many countries one IVF cycle costs more than a year's income. Hair Loss Treatments: What WorksIn 2022 the FDA approved the first pill for severe alopecia areata, which affects more than 300,000 people in…
Back to Catalogue
Keep exploring

Related Pharmaceuticals reports in New Zealand

See all
Same topic, other categories

Related on men's health and kidney health

See the topic